Anaphylaxis
Publication Date: April 1, 2020
Key Points
Key Points
- Anaphylaxis is an acute, potential life-threatening systemic allergic reaction that may have a wide range of clinical manifestations.
- Severe anaphylaxis and/or the need for repeated doses of epinephrine to treat anaphylaxis are risk factors for biphasic anaphylaxis.
- Antihistamines and/or glucocorticoids are not reliable interventions to prevent biphasic anaphylaxis.
Diagnosis
...nt Task Force suggests that a clinician i...
...t Task Force suggests extended clinical obs...
Treatment
...Treatment...
...oint Task Force suggests against ad...
...Joint Task Force suggests in favor of...
...int Task Force suggests against rout...
...oint Task Force suggests in favor administering of...
...Good Practice State...
...epinephrine as the first-line pharm...
...the administration of epinephrine for anaphylaxis...
...diagnosis and treatment of anaphylax...
...ents with anaphylaxis should receive edu...
...Suggested Key Clinical Adv...
...vere anaphylaxis and/or the need for >1 dose of...
...llustration